Global Phenotypic Drug Discovery Market Growth (Status and Outlook) 2023-2029

Global Phenotypic Drug Discovery Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Phenotypic Drug Discovery Industry Forecast” looks at past sales and reviews total world Phenotypic Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected Phenotypic Drug Discovery sales for 2023 through 2029. With Phenotypic Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phenotypic Drug Discovery industry.

This Insight Report provides a comprehensive analysis of the global Phenotypic Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenotypic Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phenotypic Drug Discovery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenotypic Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenotypic Drug Discovery.

The global Phenotypic Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Phenotypic Drug Discovery players cover Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Phenotypic Drug Discovery market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Platform
Service

Segmentation by application
Cancer
Viral Infection
Genetic Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris

Please note: The report will take approximately 2 business days to prepare and deliver.